Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29373143 | 1.00 | KDM4E (0.43) | KDM4EATML3MBTL1PDK2MAPK8 | |
| SCHEMBL12559991 | 1.00 | KDM4E (0.43) | KDM4EATML3MBTL1PDK2MAPK8 | |
| SCHEMBL18135001 | 1.00 | KDM4E (0.43) | KDM4EATML3MBTL1PDK2MAPK8 | |
| SCHEMBL12559955 | 1.00 | KDM4E (0.43) | KDM4EATML3MBTL1PDK2MAPK8 | |
| SCHEMBL17993817 | 0.99 | KDM4E (0.44) | KDM4EATML3MBTL1PDK2MAPK8 | |
| SCHEMBL20762698 | 0.98 | KDM4E (0.45) | KDM4EATML3MBTL1PDK2 | |
| SCHEMBL12559960 | 0.97 | KDM4E (0.40) | KDM4EATML3MBTL1PDK2 | |
| SCHEMBL25563626 | 0.97 | KDM4E (0.40) | KDM4EATML3MBTL1PDK2 | |
| SCHEMBL25563563 | 0.97 | KDM4E (0.40) | KDM4EATML3MBTL1PDK2 | |
| SCHEMBL21923978 | 0.96 | L3MBTL1 (0.39) | KDM4EATML3MBTL1PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230180502-A1 | LIGHT-EMITTING DEVICE INCLUDING DIAMINE COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE DIAMINE COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230180502-A1 | LIGHT-EMITTING DEVICE INCLUDING DIAMINE COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE DIAMINE COMPOUND | AOC1, DTD1, DDT | KDM4E 1826/4885ATM 2591/4885L3MBTL1 1190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.